ESR1 and breast cancer: Since miR-301 regulates the PTEN/Akt and NFκB signaling pathways that are important in the progression of BC [43, 44], and binds to estrogen receptor 1 mRNA leading to estrogen independence of BC [45], miR-301 may be an early therapeutic target molecule in BC.